Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

4.88
-0.0500-1.01%
Post-market: 4.78-0.1000-2.05%19:58 EDT
Volume:61.66K
Turnover:303.97K
Market Cap:13.94M
PE:-0.21
High:5.05
Open:4.96
Low:4.80
Close:4.93
Loading ...
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 05, 2020

Major Issues Report

8-K - Current report
Jun 03, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 01, 2020

Major Issues Report

8-K - Current report
May 26, 2020

Major Issues Report

8-K - Current report
May 20, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 20, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 14, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Public Prospectus

General form for registration of securities under the Securities Act of 1933
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 09, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 19, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals